CN103705878B - 一种治疗偏头痛中药制剂 - Google Patents
一种治疗偏头痛中药制剂 Download PDFInfo
- Publication number
- CN103705878B CN103705878B CN201310466136.7A CN201310466136A CN103705878B CN 103705878 B CN103705878 B CN 103705878B CN 201310466136 A CN201310466136 A CN 201310466136A CN 103705878 B CN103705878 B CN 103705878B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- medicine preparation
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 208000019695 Migraine disease Diseases 0.000 title claims abstract description 14
- 206010027599 migraine Diseases 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 9
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 239000006187 pill Substances 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 10
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 238000011084 recovery Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000003672 processing method Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 229940095559 cafergot Drugs 0.000 description 2
- CJMJLDQKTOJACI-SEUSHGJOSA-N chembl2448612 Chemical compound OC(=O)C(O)C(O)C(O)=O.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1.C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C=3C=CC=C4NC=C(C=34)C2)=C1)C)C1=CC=CC=C1 CJMJLDQKTOJACI-SEUSHGJOSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 102100027499 5-hydroxytryptamine receptor 1B Human genes 0.000 description 1
- 101710138639 5-hydroxytryptamine receptor 1B Proteins 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000027776 Extrapyramidal disease Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000010271 Heart Block Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002315 pressor effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000000283 vasomotion Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例次 | 治愈数 | 无效数 | 有效率(%) |
治疗组 | 2500 | 2433 | 67 | 97.3 |
对照组 | 2500 | 2260 | 240 | 90.4 |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310466136.7A CN103705878B (zh) | 2013-10-08 | 2013-10-08 | 一种治疗偏头痛中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310466136.7A CN103705878B (zh) | 2013-10-08 | 2013-10-08 | 一种治疗偏头痛中药制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103705878A CN103705878A (zh) | 2014-04-09 |
CN103705878B true CN103705878B (zh) | 2016-01-20 |
Family
ID=50399465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310466136.7A Expired - Fee Related CN103705878B (zh) | 2013-10-08 | 2013-10-08 | 一种治疗偏头痛中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103705878B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362469A (zh) * | 2015-11-17 | 2016-03-02 | 台耀军 | 一种治疗偏头痛的中药及制备方法 |
CN105362520A (zh) * | 2015-11-27 | 2016-03-02 | 天峨县平昌生态农业有限公司 | 一种治疗动脉硬化的中药制剂 |
CN105343370A (zh) * | 2015-11-27 | 2016-02-24 | 天峨县平昌生态农业有限公司 | 一种治疗偏头痛的中药制剂 |
CN105288300A (zh) * | 2015-11-30 | 2016-02-03 | 吕翠云 | 一种治疗无先兆的偏头痛的中药组合物 |
CN105943893A (zh) * | 2016-07-01 | 2016-09-21 | 覃益祥 | 一种治疗感冒引起头疼的中药 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102988536A (zh) * | 2012-10-26 | 2013-03-27 | 吴玥霖 | 一种用于治疗偏头疼的中药配方及其制备方法 |
-
2013
- 2013-10-08 CN CN201310466136.7A patent/CN103705878B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN103705878A (zh) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705878B (zh) | 一种治疗偏头痛中药制剂 | |
CN102886033B (zh) | 一种促进产后产妇恢复、缩短恶露时间的中药制剂 | |
CN101491612B (zh) | 一种治疗乳腺增生和乳腺癌早期的药物 | |
CN102698214B (zh) | 一种治疗偏头痛的中药及其制备方法 | |
CN105343370A (zh) | 一种治疗偏头痛的中药制剂 | |
CN104436121B (zh) | 一种治疗月经不调、小腹胀满、久不受孕的药物 | |
CN103191253A (zh) | 一种治疗贫血的药物及其制备方法 | |
CN101856423A (zh) | 一种治疗月经不调的药物及其制备方法 | |
CN105521150A (zh) | 一种降血脂中药的制备方法 | |
CN105456887A (zh) | 一种用于治疗再生障碍性贫血的药物 | |
CN105311460A (zh) | 一种治疗血管神经性头痛中药 | |
CN101983712A (zh) | 冠心病的新型治疗药物 | |
CN102824461A (zh) | 治疗高血压的药物及其制备方法 | |
CN103432333B (zh) | 一种治疗甲状腺机能减退症的中药有效部位组合物 | |
CN103860869A (zh) | 一种用于治疗妊娠高血压的中药 | |
CN101953943A (zh) | 一种治疗慢性再生障碍性贫血的中药 | |
CN103127417A (zh) | 一种治疗鼻窦炎的药物及其制备方法 | |
CN104435597A (zh) | 一种治疗习惯性便秘的药物及其制备方法 | |
CN105456729A (zh) | 一种治疗化疗、放疗引起的白细胞减少的药物组合物 | |
CN104306905A (zh) | 一种治疗高血压中药组合物及其制备方法 | |
CN104826043A (zh) | 一种治疗脚扭伤的中药配方 | |
CN101979051A (zh) | 一种治疗慢性胃炎的中药 | |
CN109806359A (zh) | 一种养生保健中药组合物 | |
CN105213927A (zh) | 一种治疗急性肠炎的药物及其制备方法 | |
CN104027519A (zh) | 一种用于治疗慢性盆腔炎的中药制剂及其制作方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Zhang Fujun Inventor before: Ding Huasheng |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170818 Address after: 013800 the Inner Mongolia Autonomous Region Xilinguole Meng Zhengxiangbaiqi minganto Town Farm Group No. 130 6 e Li Tu Patentee after: Zhang Fujun Address before: The Guangxi Zhuang Autonomous Region Laibin City District Vanguard road 546199 No. 13 Patentee before: Ding Huasheng |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160120 Termination date: 20171008 |